In non-COVID-19 patients with pulmonary embolism a prevalence of up to 70% of concomitant symptomatic or asymptomatic deep venous thrombosis has been reported. Physicians experience an exceptionally high prevalence of pulmonary embolism in COVID-19…
ID
Bron
Verkorte titel
Aandoening
Pulmonary embolism, deep venous thrombosis, venous thromboembolic disease, COVID-19
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients.
Achtergrond van het onderzoek
The objective of this study is to investigate whether point-of-care performed two-point CUS (2CUS) of both legs reduces the need for CTPA in COVID-19 patients.
Doel van het onderzoek
In non-COVID-19 patients with pulmonary embolism a prevalence of up to 70% of concomitant symptomatic or asymptomatic deep venous thrombosis has been reported. Physicians experience an exceptionally high prevalence of pulmonary embolism in COVID-19 patients. If the etiology is equal for COVID-19 and non-COVID-19, then numerous patients with COVID-19 and pulmonary embolism should have concomitant symptomatic or asymptomatic deep venous thrombosis.
Onderzoeksopzet
none
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
All patients with PCR confirmed COVID-19 with a clinically suspected pulmonary embolism, aged 18 years or over.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
chronic and known deep vein thrombosis (DVT), ipsi- or contralateral DVT within the previous 6 months, pregnancy
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL8625 |
| Ander register | METC Utrecht : 20-292 |